JAMA Clinical Reviews

Cesarean delivery on maternal request requires individualized counseling. Reduced risks of pelvic floor disorders should be weighed against surgical risks and future risks including abnormal placentation. Author Marianna Alperin, MD, MS, from UC San Diego School of Medicine, discusses this and more with JAMA Deputy Editor Linda Brubaker, MD.

Related Content:
Cesarean Delivery on Maternal Request
Cesarean Delivery—Reply
Cesarean Delivery

The GLP-1 receptor agonists reduce appetite and greatly facilitate weight loss. Robert Kushner, MD, of Northwestern University Feinberg School of Medicine joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss appropriate diet and exercise recommendations for patients receiving GLP-1 receptor agonists for weight loss.

Related Content:
Lifestyle Modification and Incretin-Based Therapy for Obesity
The Conundrum of Exercise for Weight Management in the GLP-1 Receptor Agonist Era

Amyotrophic lateral sclerosis (ALS), which affects about 25 000 individuals in the US, causes progressive weakness but has varied presentations. Several FDA-approved medications are now available for ALS. Author John Ravits, MD, of UC San Diego School of Medicine joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss current evidence regarding diagnosis and treatment of ALS.

Related Content:
Amyotrophic Lateral Sclerosis
Pridopidine in Amyotrophic Lateral Sclerosis
What Is Amyotrophic Lateral Sclerosis?
CNM-Au8 in Amyotrophic Lateral Sclerosis
Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis
Traumatic Brain Injury and Risk of Amyotrophic Lateral Sclerosis

Hepatitis B virus (HBV) infection affects around 254 million people worldwide and causes more than 1 million deaths annually. Author Anna Lok, MD, from the University of Michigan discusses HBV transmission, screening, and treatment with JAMA Associate Editor Beverly Forsyth, MD.

Related Content:
Hepatitis B
Hepatitis B Virus Treatment Gaps in the US
Tenofovir and Hepatitis B Virus Transmission During Pregnancy
US Newborn Hepatitis B Virus Vaccination Rates

Heart failure (HF) affects more than 64 million individuals worldwide, and 20% to 30% of patients with HF and systolic dysfunction have cardiac dyssynchrony due to conduction system disease. JAMA Review author Mihail Chelu, MD, PhD, of Baylor College of Medicine discusses cardiac resynchronization therapy with JAMA Associate Editor David Simel, MD, MHS.

Related Content:
Cardiac Resynchronization Therapy
Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure